[1] CULLEY L,LAW C,HUDSON N,et al.A qualitative study of the impact of endometriosis on male partners[J].Hum Reprod,2017,32(8):1667.
[2] ZONDERVAN KT,RAHMIOGLU N,MORRIS AP,et al.Beyond endometriosis GWAS:from genomics to phenomics to the patient[J].Semin Reprod Med,2016,34(4):242.
[3] AREDO JV,HEYRANA KJ,KARP BI,et al.Relating chronic pelvic pain and endometriosis to signs of sensitization and myofascial pain and dysfunction[J].Semin Reprod Med,2017,35(1):88.
[4] STILLEY JAW,BIRT JA,SHARPE-TIMMS KL.Cellular and molecular basis for endometriosis-associated infertility[J].Cell Tissue Res,2012,349(3):849.
[5] 仝佳丽,郎景和,冷金花,等.重度子宫内膜异位症腹腔镜术后联合GnRHa治疗效果及反加疗法的影响[J].现代妇产科进展,2008,17(11):839.
[6] 张团英,符爱珍,张凤兰,等.保守性手术后促性腺激素释放激素激动剂联合反加疗法治疗中重度子宫内膜异位症的疗效观察[J].中国妇幼保健,2007,22(33):4669.
[7] 张春燕,耿爱芝.促性腺激素释放激素激动剂联合克龄蒙在子宫内膜异位症保守性手术后的应用[J].广东医学,2013,34(3):454.
[8] 牛子儒,岳晓静,孔群钰,等.反加疗法在促性腺激素释放激素激动剂治疗内异症中减缓骨量流失的荟萃分析[J].中华妇产科杂志,2013,48(5):338.
[9] 范宝光,任琛琛.GnRHa联合反加疗法用于腹腔镜术后子宫内膜异位症的临床观察[J].国际妇产科学杂志,2013,40(1):75.
[10] 甄小文,阙贵珍,冯满欢,等.GnRHa联合反加疗法治疗保守性手术后中重度子宫内膜异位症的临床分析[J].中国现代医药杂志,2011,13(4):61.
[11] 罗静,谭广萍.盆腔子宫内膜异位症保留生育功能手术后促性腺激素释放激素联合反加疗法的疗效观察[J].中国医师进修杂志,2010,33(18):45.